ADMA Biologics, Inc. (NASDAQ: ADMA) announced following the close of the after-hours session the FDA approved Asceniv (RI-002) for the treatment of Primary Humoral Immunodeficiency Disease Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced that management will host a conference call on Tuesday, April 2nd at 8a.m. Eastern Time to provide a clinical development update. No details were provided

Traders are most likely stuck holding stocks they should have sold days and weeks ago. It usually takes any 2 or 4 weeks for them to finally give up and sell thier positions at a loss. I expect the markets to be slower in April and back in May of 2019.

* Banks climb as U.S. yields hit 1-week high * Chipmakers rise on positive China data * Lyft drops below IPO price on second day of trading * Indexes up: Dow 1.27 pct, S&P 1.16 pct, Nasdaq 1.29 pct (Updates to market close) NEW YORK, April 1 (Reuters) – U.S. stocks rallied on Monday, starting

Biotech news January 25 2019

NuCana plc (Nasdaq: NCNA) shares closed up 7% to $12.25 on news that it has withdrawn the proposed underwritten offering of American Depositary Shares (“ADSs”).  The company noted that it believes it is not in the best interest of its shareholders to raise equity capital in the current market environment.   MacroGenics, Inc. (NASDAQ: MGNX) announced that the FDA

Finally it’s over.

FINALLYIt actually happened. The longest Government shutdown will get relief. It appears a partial agreement is in place, and everyone was sharing links to this story. They’re Back!After the shutdown, some thought it was time to BTFD again. Release the memes and GIFs!  “Welcome Home.” – Amazon Alexa.The Information reported today that Amazon is exploring a partnership

Stock news

Stock news

Leds chart

[finviz ticker=leds]

NFLX chart

[finviz ticker=NFLX]

TSLA chart

[finviz ticker=TSLA]

GOOG chart

[finviz ticker=GOOG]